Stockscreener 앱 받기
14.58
0.82%
-0.12
전일 마감가:
$14.70
열려 있는:
$14.95
하루 거래량:
787.33K
Relative Volume:
0.46
시가총액:
$1.78B
수익:
-
순이익/손실:
$-115.88M
주가수익비율:
-9.4259
EPS:
-1.5468
순현금흐름:
$-104.72M
1주 성능:
-13.78%
1개월 성능:
+16.64%
6개월 성능:
-59.92%
1년 성능:
-27.10%
1일 변동 폭
$14.51
$15.55
1주일 범위
$13.82
$16.91
52주 변동 폭
$10.60
$38.12
엣지와이즈 Stock (EWTX) Company Profile
명칭
Edgewise Therapeutics Inc
전화
720-262-7002
주소
1715 38TH ST, BOULDER
EWTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
14.58 | 1.78B | 0 | -115.88M | -104.72M | -1.5468 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
엣지와이즈 Stock (EWTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-30 | 개시 | Guggenheim | Buy |
| 2025-04-02 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2025-01-22 | 개시 | Stifel | Hold |
| 2024-11-22 | 개시 | Evercore ISI | Outperform |
| 2024-03-07 | 개시 | Piper Sandler | Overweight |
| 2023-05-01 | 개시 | Truist | Buy |
| 2022-08-25 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-04-13 | 개시 | RBC Capital Mkts | Outperform |
| 2022-01-28 | 개시 | Goldman | Neutral |
모두보기
엣지와이즈 주식(EWTX)의 최신 뉴스
Cubist Systematic Strategies LLC Makes New Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by DAFNA Capital Management LLC - MarketBeat
Driehaus Capital Management LLC Decreases Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Deerfield Management Company L.P. Series C Boosts Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Bamco Inc. NY Makes New $1.60 Million Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Algert Global LLC Acquires 100,859 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Deep Track Capital LP Trims Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics Reports Strong Q1 2025 Progress - TipRanks
Wedbush Adjusts Price Target on Edgewise Therapeutics to $40 From $43, Maintains Outperform Rating - marketscreener.com
Edgewise Therapeutics shares fall on in-line Q1 results By Investing.com - Investing.com UK
EDGEWISE THERAPEUTICS Earnings Results: $EWTX Reports Quarterly Earnings - Nasdaq
Edgewise Therapeutics, Inc. SEC 10-Q Report - TradingView
Edgewise Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights - PR Newswire
Braidwell LP Raises Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Purchased by Baker BROS. Advisors LP - MarketBeat
Schonfeld Strategic Advisors LLC Reduces Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics Executives Sell Shares to Cover Tax Obligations - TradingView
Ally Bridge Group NY LLC Sells 104,519 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Acuta Capital Partners LLC Buys 24,658 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Invesco Ltd. Sells 21,341 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (EWTX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Acquired by Envestnet Asset Management Inc. - Defense World
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is Novo Holdings A S's 4th Largest Position - MarketBeat
Marshall Wace LLP Has $798,000 Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Now Covered by Guggenheim - MarketBeat
Voya Investment Management LLC Lowers Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Is Edgewise Therapeutics, Inc. (EWTX) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - Insider Monkey
Adage Capital Partners GP L.L.C. Purchases 218,491 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Foresite Capital Management VI LLC Buys New Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Top 11 Small Cap Stocks to Buy with Biggest Upside Potential - Insider Monkey
First Light Asset Management LLC Purchases Shares of 780,639 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Why Edgewise Therapeutics Stock Popped This Week - The Globe and Mail
Edgewise Therapeutics (EWTX) Initiated at Buy by Guggenheim, Pot - GuruFocus
Edgewise a new buy at Guggenheim on two pipeline prospects - Seeking Alpha
Edgewise Therapeutics (EWTX) Receives Positive Coverage with Str - GuruFocus
Guggenheim Starts Edgewise Therapeutics With Buy Rating, $41 Price Target - marketscreener.com
79,381 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Bought by Harvest Investment Services LLC - MarketBeat
JPMorgan Chase & Co. Sells 34,071 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Russell Investments Group Ltd. Makes New $883,000 Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics' (EWTX) Outperform Rating Reaffirmed at Wedbush - MarketBeat
Analysts Set Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Price Target at $40.38 - MarketBeat
Is Edgewise Therapeutics Inc. (NASDAQ:EWTX) the Most Promising Small-Cap Stock According to Analysts? - Insider Monkey
Jump Financial LLC Sells 76,628 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
엣지와이즈 (EWTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
엣지와이즈 주식 (EWTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Russell Alan J | Chief Scientific Officer |
May 02 '25 |
Sale |
16.45 |
1,551 |
25,520 |
18,521 |
| MOORE JOHN R | General Counsel |
May 01 '25 |
Option Exercise |
0.00 |
5,209 |
0 |
8,461 |
| MOORE JOHN R | General Counsel |
May 02 '25 |
Sale |
16.45 |
1,930 |
31,757 |
6,531 |
| KOCH KEVIN | President and CEO |
May 01 '25 |
Option Exercise |
0.00 |
10,417 |
0 |
24,895 |
| KOCH KEVIN | President and CEO |
May 02 '25 |
Sale |
16.45 |
4,276 |
70,358 |
20,619 |
| Donovan Joanne M. | CMO |
May 01 '25 |
Option Exercise |
0.00 |
10,417 |
0 |
26,775 |
| Donovan Joanne M. | CMO |
May 02 '25 |
Sale |
16.45 |
5,187 |
85,348 |
21,588 |
| Derakhshan Behrad | Chief Business Officer |
May 01 '25 |
Option Exercise |
0.00 |
5,209 |
0 |
22,046 |
| Derakhshan Behrad | Chief Business Officer |
May 02 '25 |
Sale |
16.45 |
1,691 |
27,824 |
20,355 |
| Carruthers R Michael | Chief Financial Officer |
May 01 '25 |
Option Exercise |
0.00 |
5,209 |
0 |
82,328 |
0.84%
0.15%
자본화:
|
볼륨(24시간):